Despite the requirement for Scleraxis-lineage (Scx Lin ) cells during tendon development, the function of Scx Lin cells during adult tendon repair, post-natal growth, and adult homeostasis have not been defined. Therefore, we crossed Scx-Cre and Diphtheria Toxin Receptor (DTR) mouse models to inducibly deplete Scx Lin cells prior to acute flexor tendon injury and repair (ScxLin DTR ) and hypothesized that ScxLin DTR mice would exhibit worse healing than wildtype littermates. Surprisingly, depletion of Scx Lin cells resulted in increased biomechanical properties without detriments to tendon gliding function at 28 days post-repair, indicative of regeneration. These improvements in biomechanical properties correspond to increased αSMA+ myofibroblasts in ScxLin DTR repairs, indicating that increased myofibroblast-mediated matrix remodeling may be responsible for accelerated recovery of tensile strength. Furthermore, we have defined the relative timing of Scx Lin cell localization relative to collagen deposition in bridging tissue of the repair and demonstrated a predominance of non-Scx Lin cells in the early bridging tissue, consistent with lack of bridging tissue disruption in ScxLin DTR repairs. Lastly, we utilized ScxLin DTR mice to assess effects of tendon cell depletion on post-natal tendon growth and adult tendon homeostasis. Collectively, these findings enhance our understanding of tendon cell localization, function, and fate during healing, growth, and homeostasis.
Ablation of Scleraxis-lineage cells results in significantly increased biomechanical properties by day 28 post repair while not affecting gliding function.
To define the functional effects of Scx Lin c ell depletion on tendon healing, mice received five DT injections to deplete Scx Lin cells followed by FDL repair 10 days following the final injection ( Fig. 2A ). ScxLin DTR repairs were trending towards increased MTP range of motion at day 14 relative to WT littermates (WT vs ScxLin DTR , p = 0.0711), but this trend was absent by day 28 post-repair ( Fig. 2B ). ScxLin DTR healing tendons did not significantly differ in gliding resistance at either day 14 or 28 post-repair ( Fig. 2C ). While biomechanical properties were not altered between groups at day 14, both stiffness and maximum load at failure were significantly increased in ScxLin DTR healing tendons relative to wildtype littermates at day 28 post-repair (Stiffness: WT: 6.48 + 0.75, ScxLin DTR : 11.22 + 1.83 , p = 0.0237; Maximum load at failure: WT: 1.54 + 0.17, 6 ScxLin DTR : 2.44 + 0.24 , p = 0.0061) ( Fig. 2D and E) . Between days 14 and 28, WT tendon stiffness increased by 39.06% while ScxLin DTR stiffness increased by 109.33%, and WT tendon maximum load at failure increased by 52.48% while ScxLin DTR maximum load at failure increased by 162.37%, indicating that ScxLin DTR repairs heal at an accelerated rate relative to wildtype littermates.
Scleraxis-lineage cells are not required for the formation of a bridging collagen matrix during tendon healing.
We have previously demonstrated that bridging tendon cells correspond to a region of bridging collagen matrix in the scar tissue (4) . While there were no apparent differences in tissue morphology between groups at days 14 or 28 post-repair ( Fig. 3B) , we wanted to determine if tendon cell depletion prevented formation of the bridging collagen. Masson's trichrome staining revealed presence of bridging collagen through the scar in both groups at days 14 and 28, indicating that depletion of Scx Lin tendon cells does not prevent formation of the bridging collagen matrix (Fig. 3C ).
Scx Lin Depletion enhances myofibroblast content during tendon healing.
We have previously demonstrated that elevated F4/80+ macrophages and αSMA+ myofibroblasts are associated with increased tendon maximum load at failure (24) . No significant differences in F4/80+ macrophages were detected between genotypes at either day 14 or 28 post-repair ( Fig. 4B ). While αSMA+ myofibroblasts were not significantly altered at day 14 (D14: WT vs DTR, p = 0.3790), ScxLin DTR healing tendons had significantly increased levels of αSMA+ myofibroblasts relative to wildtype littermates at D28 (p = 0.0188) ( Fig. 4C ). We have previously demonstrated that S100a4 is an important molecule that can influence tendon biomechanical properties and gliding function during flexor tendon healing (25) . No differences in S100a4+ cells were observed in ScxLin DTR , relative to WT at either day 14 or 28 post-repair ( Fig. 4D ). Thus, αSMA+ myofibroblasts are the most likely contributor to the increased biomechanical properties seen in ScxLin DTR 7 healing tendon. However, little is understood about the varied functions and sources of αSMA+ myofibroblasts during tendon healing.
Tendon cells do not differentiate into myofibroblast by day 28 post-repair.
We have previously reported that while many Scx Ai9 tendon cells residing within the tendon stubs during healing differentiate into αSMA+ expressing myofibroblasts, the majority of bridging Scx Ai9 tendon cells do not differentiate into myofibroblasts by 14 days post-repair in mouse flexor tendons (4) . To assess if bridging tendon cells differentiate into αSMA+ myofibroblasts during later stages of healing, co-immunofluorescence of tdTomato (labels Scx Ai9 cells) and αSMA was performed. While tendon cells in the stubs continued to express αSMA, bridging tendon cells had still not differentiated into myofibroblasts by 21 or 28 days post-repair ( Fig.   5B and C). It has previously been demonstrated that approximately 65% of αSMA-lineage cells express Scx at day 14 post-injury in patellar tendon. To confirm that actively expressing αSMA+ myofibroblasts express Scx post-injury, Scx-Cre ERT2 ; ROSA-Ai9 F/F mice were injected with TAM on days 10-12 post-repair to label cells expressing Scx near the time of a day 14 harvest (Scx 10-12 ) ( Fig. 5D ). Essentially all αSMA+ myofibroblasts express Scx by day 14 post-flexor tendon repair ( Fig. 5E ), suggesting that Scx expressing myofibroblasts in the bridging region are not derived from Scx Ai9 cells that are labelled in the adult tendon prior to injury.
Robust tendon cell bridging is first detected at day 10 post-repair and corresponds to organized collagen matrix in the scar.
We have previously demonstrated that Scx Ai9 tendon cells bridge the injury site by 14 days post-repair and these bridging Scx Ai9 cells correspond to a bridging, linear collagen matrix in the scar(4), and have established that depletion of Scx Lin cells does not disrupt formation of this collagenous bridge ( Fig. 3 ). However, further exploration of the timing of collagen formation and bridging Scx Ai9 could be informative as to Scx Ai9 cell function. Scx Ai9 cells are not found in the scar at day 7 post-repair, indicating the cellular bridge forms between days 7 and 14 post-repair(4). To determine when Scx Ai9 cells first bridge the injury site and how this compares 8 to development of bridging collagen matrix, Scx Ai9 mice were harvested at 8, 10, and 12 days post-repair and assessed for Scx Ai9 cell localization and collagen deposition ( Fig. 6A ). Although a few bridging Scx Ai9 cells were observed in approximately half of the day 8 repair samples, Scx Ai9 cells were consistently bridging by day 10 post-repair ( Fig. 6B and C). A defined collagen bridge is first present at day 10 post-repair ( Fig. 6C ), but is not as robust as the collagen bridge present at 14 days post-repair (4) . Bridging Scx Ai9 cells and bridging collagen matrix are both present at day 12 ( Fig. 6D ) and are comparable with day 14 repairs(4). Interestingly, the cells existing at the bridging collagen boundary are predominantly non-Scx Ai9 , suggesting a different population may be defining, and possibly producing, the collagen bridge ( Fig. 6C and D, yellow arrows).
Scx Ai9 tendon cells proliferate at both the tendon stub and bridging tissue throughout healing.
It is unknown if bridging Scx Ai9 cells are derived from pre-existing Scx Ai9 cells that have migrated into the scar tissue space or from newly derived Scx Ai9 produced through proliferation that then expand into the scar. Studies examining proliferative capability of adult tendon cells during healing are limited, but most findings indicate a low proliferative ability of tendon cells during healing (11, 12, 26) . To assess in vivo proliferative capability of Scx Ai9 tendon cells during flexor tendon healing, Scx Ai9 tendons were stained for PCNA at days 8, 10, 12, 14, 21, and 28 post-repair ( Fig. 7A ). While there are PCNA+ Scx Ai9 cells in both the tendon stub and bridging scar tissue at days 8 and 10 post-repair ( Fig. 7B and C), proliferation of Scx Ai9 cells appeared to peak between days 12 and 14 at both the stub and bridging regions ( Fig. 7D and E). While many Scx Ai9 cells within the stub remained PCNA+ at day 21 post-repair, bridging Scx Ai9 cells were almost exclusively PCNA-( Fig. 7F ). By day 28 post-repair, only a few Scx Ai9 cells in the stub were PCNA+ and no bridging Scx Ai9 cells were proliferating ( Fig. 7G ). Therefore, bridging Scx Ai9 cells may be derived from both newly proliferated cells that emanate from the stub and proliferation of Scx Ai9 cells that have already migrated into the bridge. 9 Ablation of Scx Lin tendon cells does not significantly affect tendon post-natal growth 3 months postablation.
Local injection of DT into pre-pubescent mice (3-4 weeks old) resulted in 55% depletion of tendon cells in uninjured ScxLin DTR FDL tendons relative to WT littermates (p = 0.0007) ( Fig. 8A-C) . To assess the requirement for tendon cells in post-natal growth, pre-pubescent mice who were still undergoing periods of rapid growth were injected with DT and harvested at the 3-month timepoint (ScxLin DTR,3weeks ) ( Fig. 8D ). There were no significant changes in MTP range of motion, gliding resistance, stiffness, or maximum load at failure between groups ( Fig. 8E-H ). Second harmonic generation revealed no significant differences in collagen fibril dispersion between genotypes ( Fig. 8I and J). ScxLin DTR,3weeks tendons did not exhibit an influx of F4/80+ macrophages or tendon cell differentiation into αSMA+ myofibroblasts in either genotype ( Fig. 8K ); however, ScxLin DTR mice had a 42.5% decreased tendon cell number relative to WT littermates (p = 0.0454) ( Fig. 8K and L).
Ablation of Scx Lin tendon cells does not significantly affect tendon homeostasis 3 months post-depletion.
To assess the requirement for Scx Lin tendon cells in maintaining tendon homeostasis, adult (10-12 weeks) ScxLin DTR mice were injected with DT to induce cell death and harvested after 3 months (ScxLin DTR,10weeks ) ( Fig. 9A ). There were no significant changes in tendon gliding function or biomechanical properties between genotypes after 3 months ( Fig. 9B -E). While ScxLin DTR,10weeks animals were trending towards decreased maximum load at failure relative to WT littermates, these differences did not reach significance (WT: 9.16 + 0.57, ScxLin DTR,10weeks : 7.63 + 0.51, p = 0.0677) ( Fig. 9E ). Second harmonic generation revealed a trending increase in collagen fibril dispersion in ScxLin DTR,10weeks relative to WT littermates (WT: 9.085 + 0.72, ScxLin DTR,10weeks : 11.15 + 0.53, p=0.0806) ( Fig. 9F and G) . ScxLin DTR,10weeks tendons did not exhibit an influx of F4/80+ macrophages or tendon cell differentiation into αSMA+ myofibroblasts in either genotype (Fig. 9H) ; however, ScxLin DTR mice had a 41% decreased tendon cell number relative to WT littermates (p = 0.0358) ( Fig.   9H and I).
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Discussion:
In the present study we examined the function of Scx Lin tendon cells during healing and made the surprising discovery that Scx Lin cell depletion significantly enhanced biomechanical properties by day 28 post-repair.
Additionally, we further characterized the localization, proliferative ability, and fate of Scx Lin tendon cells during healing. Lastly, we examined the effects of Scx Lin cell depletion on post-natal tendon growth and adult tendon homeostasis.
Tendon cell depletion had surprisingly beneficial effects on healing, with biomechanical properties significantly increased at day 28 post-repair relative to WT controls with no impact on gliding function. These results indicate that the improved biomechanical properties are not due to increased levels of matrix/scar components within the healing tendon, but that the healing process is shifted towards a regenerative phenotype.
Equally striking is that the significant improvements in biomechanical properties did not emerge until 28 days post-repair, which is firmly into the remodeling phase of healing. This suggests that Scx Lin cells are important in the late proliferative-remodeling phases of healing and possibly enact their greatest effects by modulating the remodeling process. It has previously been reported that tendon strength is still significantly decreased relative to uninjured controls 63 days post-repair using this model (27) . Therefore, it could be beneficial to examine time points beyond day 28 to see if ScxLin DTR tendons reach equivalency with uninjured controls. The improved biomechanical properties contrasted with our original hypothesis where we predicted Scx Lin cells would be necessary for proper healing and would contribute to formation of the bridging collagen tissue. Both ScxLin DTR and WT mice exhibited a collagen bridge at 14 and 28 days post-repair suggesting that Scx Lin cells are not the predominant cell population laying down this collagenous matrix. This is surprising due to studies demonstrating Scx promotes collagen formation (11, 20) , but highlights the important distinction between Scx Lin cells and active Scx expression.
While myofibroblast persistence is considered a primary driver of fibrosis(28), recent work has revealed that myofibroblasts are a highly heterogenous population with differences in pro-fibrotic markers, gene expression, and cross-linking ability, suggesting that myofibroblasts contribute to both fibrotic and regenerative processes (29) . Despite the elevated myofibroblast presence in ScxLin DTR repairs at day 28, these tendons healed with increased biomechanical properties while experiencing no deficits in tendon range of motion, suggesting a more regenerative healing process. Future work to assess the myofibroblast landscape in both WT and ScxLin DTR mice is necessary to determine if ScxLin DTR myofibroblasts are more "pro-regenerative" than those present in WT controls. Related to this, the cell-lineage of myofibroblast origin is also associated with function.
We have previously shown that Scx Ai9 in the bridging collagen matrix do not become myofibroblasts at D14.
Consistent with this, the bridging tendon cells remained αSMAthrough day 28 of healing, suggesting that bridging Scx Ai9 tendon cells are resistant to myofibroblast differentiation. We also demonstrated that most αSMA+ myofibroblasts are actively expressing Scx by day 14 post-repair, suggesting a non-Scx Ai9 population that differentiates into αSMA+ myofibroblasts and expresses Scx during healing (Fig. 5E ). Developing a better understanding of distinctive stub vs bridging Scx Ai9 tendon cell differentiation patterns, delineating lineagespecific myofibroblast populations, and analysis of the relationship between Scx expression and αSMA+ myofibroblast differentiation will greatly enhance our understanding of tendon healing.
In addition to investigating the role of tendon cells during healing, we also utilized ScxLin DTR mice to assess how tendon cell ablation affected post-natal growth (ScxLin DTR,3weeks ) and homeostasis (ScxLin DTR,10weeks ).
Although there were no significant differences in gliding function or biomechanical properties between ScxLin DTR and WT genotypes in either age group, ScxLin DTR,10weeks animals were trending towards decreased maximum load at failure relative to wildtype controls 3 months following the final injection (p = 0.0677) while also trending towards increased collagen fibril dispersion (p = 0.0806). This suggested that loss of Scx Lin cells may be detrimental to tendon tissue maintenance, but that negative biomechanical and organizational effects are not manifested until later than 3-months post-depletion. Future studies looking beyond the 3-month time-point will be informative to understand the role of tendon cells on maintenance of tendon tissue. It is also possible that negative effects on tendon biomechanical properties could be the result of Scx Lin cell death in non-tendon tissues, such as muscle in the hindpaw (30) . Despite nearly identical depletion efficiencies between ScxLin DTR,3weeks and ScxLin DTR,10weeks animals, only ScxLin DTR,10weeks tendons were trending towards disorganization and impaired biomechanical properties. This suggests possible differences in tendon cell subpopulations present during growth and homeostasis, as well as the potential contribution of extrinsic progenitor populations to tendon growth (13) , such that depletion could differentially impact post-natal growth and adult tendon homeostasis.
Initial plans to deplete tendon cells using the inducible Scx-Cre ERT2 crossed to the diphtheria toxin A mouse(31), but insufficient recombination occurred and targeted cell death was not achieved. Therefore, to successfully deplete tendon cells Scx-Cre mice were crossed to a diphtheria toxin receptor mouse model (ScxLin DTR ) (32) . The initial attempt to deplete cells using this model employed a series of intraperitoneal injections (200ng/day) and resulted in all ScxLin DTR mice dying within four days of the initial injection while WT animals were unaffected. ScxLin DTR mice likely died due to apoptosis of non-tendon/ligament associated Scx Lin cells. For example, it has previously been shown that Scx is expressed in the lung (23, 33) , kidney(23), muscle (30) , and brain,(33) among others. Therefore, to successfully utilize this model of cell depletion while simultaneously preventing ScxLin DTR associated mouse death, a series of low-dose (20 ng/day) local hindpaw injections were administered. We successfully utilized this model of in vivo tendon cell depletion and reached a depletion level of 57%. Therefore, the ScxLin DTR data should be viewed as a model of partial depletion as ~40% of tendon cells remained using this approach. Future work utilizing increased or prolonged DT treatment could be attempted to obtain more complete tendon cell depletion. The beneficial effects of tendon cell depletion may be reversed with complete ablation of Scx Lin cells from the tendon. Additionally, our current ScxLin DTR ablation model targets cells prior to injury and thus does not target any cells that turn on Scx after injury. It has previously been shown that Scx knockout during Achilles tendon healing drives incomplete remodeling of type III collagen to type I collagen (11) . It could be interesting to assess if depletion of cells actively expressing Scx during healing resulted in deleterious effects on healing. However, local DT injection into the hindpaw following repair surgery would likely be difficult as the repair site could easily be disturbed.
Altogether, these data demonstrate that Scx Lin cell depletion is beneficial for tendon healing as it increases biomechanical properties such as maximum load at failure several weeks after repair, and this may be 13 due to an αSMA+ myofibroblast-mediated mechanism. Furthermore, bridging Scx Ai9 cells do not differentiate into αSMA+ myofibroblasts following FDL injury and repair, but do readily proliferate and have a clear relationship with bridging collagen in the scar. Lastly, Scx Lin depletion does not significantly disrupt tendon post-natal growth or homeostasis by 3 months post-repair; however, these data suggest that homeostasis may be disrupted in the long-term following depletion. Understanding the complex nature of tendon cells during healing, growth, and homeostasis can provide us with insights for driving regenerative healing and healthy tendon maintenance in the future. Pre-pubescent mice (3-4 weeks old) received five hindpaw injections of DT and were harvested ten days after the final injection to assess tendon cell depletion (ScxLin DTR ) (A). Hindpaw sections from both WT and ScxLin DTR hindpaws (B). Quantification of WT and ScxLin DTR,3weeks tendon cell number in pre-pubescent mice (C). To assess effects of tendon cell depletion on post-natal tendon growth, mice received five hindpaw injections of DT on consecutive days at 3-4 weeks of age and were harvested uninjured 3 months later for biomechanical, gliding, and histological evaluation (ScxLin DTR,3weeks ) (D). Measurement of metatarsophalangeal (MTP) joint flexion angle (E), gliding resistance (F), stiffness (G), and maximum load at failure (H) of WT and ScxLin DTR,3weeks uninjured tendons. N=7-10 per genotype. Second harmonic generation (I) and quantification (J) of collagen fibril dispersion of WT and ScxLin DTR,3weeks . Co-immunofluorescence of F4/80 (macrophages) and αSMA (myofibroblasts) in uninjured WT and ScxLin DTR,3weeks tendons (K). Quantification of WT and ScxLin DTR,3weeks tendon cell number (L). Nuclei stained with DAPI. Tendon is outlined by white dotted lines. N=3 per genotype. For SHG, 3 sections from 3 samples per genotype were imaged and used for quantification. Student's t-test used to assess statistical significance between genotypes. * indicates p < 0.05, *** indicates p < 0.001.
Figure 9. Tendon cell ablation does not negatively affect tendon homeostasis 3 months post-ablation.
Mice received five hindpaw injections of DT on consecutive days at 10-12 weeks of age and were harvested uninjured 3 months later for biomechanical, gliding, and histological evaluation (ScxLin DTR,10weeks ) (A). Measurement of metatarsophalangeal (MTP) joint flexion angle (B), gliding resistance (C), stiffness (D), and maximum load at failure (E) of WT and ScxLin DTR,10weeks uninjured tendons. N=7-8 per genotype. Second harmonic generation (SHG) (F) and quantification (G) of collagen fibril dispersion of WT and ScxLin DTR,10weeks ). Co-immunofluorescence of F4/80 (macrophages) and αSMA (myofibroblasts) in uninjured WT and ScxLin DTR tendons (H). Nuclei stained with DAPI. Tendon is outlined by white dotted lines. Quantification of WT and ScxLin DTR,10weeks tendon cell number (I). N=3 per genotype. For SHG, 3 sections from 3 samples per genotype were imaged and used for quantification. Student's t-test used to assess statistical significance between genotypes. * indicates p < 0.05.
